Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

TRA-SCH-530348

Drug (Brand/Generic)

TRA-SCH 530348

Company/Licensee

Schering-Plough

Therapy Class

Thrombin-receptor antagonist

Product Description

Blocks the platelet PAR-1 receptor to which thrombin binds

Current Indication

ACS

Market Sector

Cardiovascular

Development Status

Phase III
Expand

Go Top